Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Following a major outbreak involving the use of tear drops in 13 US states, experts are offering advice on how to protect dry eyes.
Read Full NewsA study of nearly 1 million veterans suggests that simpler lung cancer screening eligibility — based on smoking duration — would sharply reduce missed cancers and narrow disparities.
A large population study of young Black women aged 50 years or younger with invasive breast cancer highlights the importance of genetic testing in this population.
Eligible men with early prostate cancer can now be offered a high-precision radiotherapy technique on the NHS in England.
1.
Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type
2.
High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment
3.
How access to specialized cancer centers affects glioblastoma outcomes
4.
Smart exercise planning could boost recovery for people with cancer
5.
Lung nodules seen in a high percentage of non-smokers
1.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
2.
A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease
3.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
4.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
5.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge